# A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects

> **NCT02792998** · PHASE1 · COMPLETED · sponsor: **Cyclerion Therapeutics** · enrollment: 67 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** IW-1701
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02792998
- **Lead sponsor:** Cyclerion Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792998, "A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02792998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*